10:49 EST Bristol Myers reaffirms all financial targets
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on BMY:
- The biopharmaceuticals stocks to own in 2024, according to BofA
- Bristol Myers downgraded to Neutral at BofA as more clarity on execution awaited
- Bristol Myers downgraded to Neutral from Buy at BofA
- Bristol Myers’ repotrectinib application validated by EMA
- Edgewise shares still reflect limited credit for EDG-7500, says Wedbush